Brain Stimulation for Speech Motor Learning

N/A

Recruiting

Led By David Ostry

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

no known physical or neurological abnormalities

Be between 18 and 65 years old

Must not have

currently taking antianxiety drugs

history of concussion

Timeline

Screening 3 weeks

Treatment Varies

Follow Up single day experiment

Awards & highlights

No Placebo-Only Group

Summary

This trial will study whether suppressing activity in a certain area of the brain affects a person's ability to learn.

Who is the study for?

This trial is for right-handed adults with no known physical or neurological abnormalities. It's not suitable for those with metal in their body, claustrophobia, on antipsychotic/antidepressant/antianxiety drugs, pregnant women, anyone with heart clips or implants, a history of concussion or epilepsy.

What is being tested?

The study tests how suppressing activity in part of the brain (Brodmann area 46v) using cTBS affects learning speech movements and sounds. The focus is on understanding memory's role in speech motor learning.

What are the potential side effects?

cTBS may cause discomfort at the stimulation site, mild headaches or lightheadedness post-treatment. There could be temporary changes to skin sensation or twitching during application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have any known physical or neurological abnormalities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently on medication for anxiety.

Select...

I have had a concussion before.

Select...

I am currently on antidepressant medication.

Select...

I am currently on antipsychotic medication.

Select...

I have surgical clips or valves in my heart.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ performance as measured at the end of learning (single day experiment)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~performance as measured at the end of learning (single day experiment)

This trial's timeline: 3 weeks for screening, Varies for treatment, and performance as measured at the end of learning (single day experiment) for reporting.